Cited by 158

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

LDL particle size distribution. Results from the Framingham Offspring Study.

Campos, H, Blijlevens, E, McNamara, J R, Ordovas, J M, Posner, B M, Wilson, P W, Castelli, W P, Schaefer, E J·1992·Arteriosclerosis and Thrombosis: A Journal of Vascular Biology

Abstract

Using 2-16% gradient gel electrophoresis, we examined low density lipoprotein (LDL) particle size in relation to plasma lipoproteins in 1,168 women and 1,172 men from the Framingham Offspring Study. In addition, we studied the effect of dietary intake on LDL size in a subset of the population. Seven LDL size peaks were identified, with the largest, LDL 1, being found in the density range 1.019-1.033 g/ml; LDL 2 and LDL 3 in d = 1.033-1.038 g/ml; LDL 4 and LDL5 in d = 1.038-1.050 g/ml; and the smallest, LDL 6 and 7, in d = 1.050-1.063 g/ml. Seventy-seven percent of the population had one major and at least one minor LDL peak. Secondary LDL peaks accounted for 23% of the total LDL relative area, based on laser scanning densitometry. LDL size distribution was skewed toward larger LDL particles in women (prevalence of LDL 1, 30% and of LDL 2, 31%), whereas men exhibited a more symmetric distribution (prevalence of LDL 3, 42%). The prevalence of small (< 255 A), dense (d > 1.038 g/ml) LDL particles 4-7 was 33% in men, 5% in premenopausal women, and 14% in postmenopausal women. In agreement with previous reports, small, dense LDL particles were significantly (p < 0.0001) associated with increased triglyceride and apolipoprotein (apo) B levels and decreased HDL cholesterol and apo A-I levels. In addition, we found a significant (p < 0.0001) association between LDL cholesterol and LDL size. The highest LDL cholesterol levels were found among women with LDL 4 (148 mg/dl) and men with LDL 3-5 (138 mg/dl). In addition, the presence of LDL 3 or 4 as secondary peaks was significantly associated with higher LDL cholesterol levels, while smaller secondary LDL peaks were associated with higher triglyceride levels. We also found that compared with subjects with optimal LDL cholesterol levels (< 130 mg/dl), individuals with high-risk LDL cholesterol levels (> or = 160 mg/dl) had 1) a higher prevalence of LDL 3 and 4 (women only) and a lower prevalence of LDL 1 and 2 (women only) and 2) 11% higher LDL cholesterol to apo B ratios, even when matched for LDL particle size. Furthermore, low saturated fat and cholesterol intakes were significantly associated (p < 0.01) with smaller LDL particles. Therefore, the identification of small, dense LDL particles per se may not be a good indicator of coronary artery disease risk in population studies.(ABSTRACT TRUNCATED AT 400 WORDS)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.12.12.1410

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Mahley RW, Innerarity TL, Rail SC Jr, Weisgraber KH: Plasma lipoproteins: Apolipoprotein structure and function. / Lipid Res 1984;25:1277-1294
  2. Yang CY, Chen SH, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, Li WH, Sparrow DA, DeLoof H, Rosseneu M, Lee FS, Gu ZW, Gotto AMJ, Chan L: Sequence, structure, receptor- binding domains and internal repeats of human apolipoprotein B-100. Nature 1986;323:738-742
  3. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families: The Framingham Offspring Study. Am J Epidemiol 1979;110:281-290
  4. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO: Apopro- teins B and A-I and coronary artery disease in humans. Arterio- sclerosis 1984;4:79-83
  5. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. / Lipid Res 1982;23:97-104
  6. Nichols AV, Krauss RM, Musliner TA: Nondenaturing poh/acryl- amide gradient gel electrophoresis. Methods Enzymol 1986;128: 417-431
  7. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ: Effect of gender, age, and lipid status on low density lipoprotein subtraction distribution: Results of the Framingham Offspring Study. Arteriosclerosis 1987;7:483-490
  8. Swinkels DW, Demacker PNM, Hendricks JCM, van't Laar A: Low density lipoprotein subtractions and relationship of other risk factors for coronary artery disease in healthy individuals. Arterio- sclerosis 1989;9:604-613
  9. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM: Inheritance of low-density lipoprotein subclass patterns: Results of complex segregation analysis. Am J Hum Genet 1988;43:838-846
  10. Austin MA, Brunzell JD, Fitch WL, Krauss RM: Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1990;10:520-530
  11. Williams PT, Krauss RM, Kindel-Jovce S, Dreon DM, Vranizan KM, Wood PD: Relationship of dietary fat, protein, cholesterol, and fiber intake to atherogenic lipoproteins in men. Am J Clin Nutr 1986;44:788-797
  12. Lamon-Fava S, Fisher EC, Nelson ME, Evans WJ, Millar JS, Ordovas JM, Schaefer EJ: Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size, and apolipoproteins. / Chn Endocrinol Metab 1989;68:17-21
  13. Campos H, Willett WC, Peterson RM, Siles X, Bailey SM, Wilson PWF, Posner BM, Ordovas JM, Schaefer EJ: Nutrient intake comparisons between Framingham and rural and urban Puriscal, Costa Rica: Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. Arterioscler Thromb 1991; 11: 1089-1099
  14. Campos H, Bailey SM, Gussak LS, Siles X, Ordovas JM, Schaefer EJ: Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb 1991;11: 1077-1088
  15. Lamon-Fava S, Jimdnez D, Christian JC, Fabsitz RR, Reed T, Carmelli D, Castelli WP, Ordovas JM, Wilson PWF, Schaefer EJ: The NHLBI Twin Study: Heritability of apolipoprotein A-I and B, and low density lipoprotein subclasses and concordance for lipo- protein (a). Atherosclerosis 1991;91:97-106
  16. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-1921
  17. Crouse JR, Parks JS, Schey HM, Kahl FR: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 1985;26:566-574
  18. Swinkels DW, Demacker P, Hendriks J, Brenninkmeijer BJ, Stuyt P: The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors. Atherosclerosis 1989;77:59-67
  19. Campos H, Genest J, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12:187-195
  20. Ordovas JM, Peterson JP, Santaniello P, Cohn JS, Wilson PWF, Schaefer EJ: Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J Lipid Res 1987;28:1216-1224
  21. Krauss RM: Relationship of intermediate and low-density lipopro- tein subspecies to risk of coronary artery disease. Am Heart J 1987;113:578-582
  22. The Expert Panel: Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36-69
  23. Krauss RM, Lindgren FT, Ray RM: Interrelationships among subgroups of serum lipoproteins in normal human subjects. Clin Own Ada 1980;104:275-290
  24. Campos H, Mata L, Siles X, Vives M, Ordovas JM, Schaefer EJ: Prevalence of cardiovascular risk factors in rural and urban Puriscal, Costa Rica. Circulation 1992;85:648-658
  25. Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO Jn Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipi- demia and familial hypercholesterolemia. Proc NatlAcad Sci U SA 1983;80:6662-6666
  26. Patsch W, Ostlund R, Kuisk I, Levy R, Schonfeld G: Character- ization of lipoprotein in a kindred with familial hypercholesterol- emia. J Upid Res 1982;23:1196-1205
  27. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subtraction in healthy subjects. Arteriosckr Thromb 1991;ll:298-3O6 38. Krauss RM: Low-density lipoprotein subclasses and risk of coro- nary artery disease. Curr Opin Lipidol 1991;2:248-252
  28. Rudel LL, Pitts LL, Nelson CA: Characterization of plasma low density lipoproteins on non-human primates fed dietary choles- terol. J Upid Res 1977;18:211-222
  29. Rudel LL, Bond MG, Bullock BC: LDL heterogeneity and ath- erosclerosis in nonhuman primates. Ann N Y Acad Sci 1985;454: 248-253
  30. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ: Abnormalities in very low, low, and high density lipoproteins in hypertrigryceridemia: Reversal toward normal with bezafibrate treatment. / Chn Invest 1984;74:470-482
  31. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S: Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 1984;4:225-231
  32. LaBelle M, Krauss RM: Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. / Upid Res 1990;31:1577-1588
  33. Rubinstein A, Gibson JC, Paterniti JR, Kakis G, Little A, Ginsberg HN, Brown WV: Effect of heparin-induced liporysis on the distri- bution of apolipoprotein E in hepatic triglyceride lipase and lipo- protein lipase. J Clin Invest 1985;75:710-721
  34. Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD: Large buoy- ant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 1989;9:319-325
  35. Campos H, Dreon DM, Krauss RM: Variations in hepatic lipase and lipoprotein lipase associated with low density lipoprotein sub- class patterns, (abstract) Circulation 1991;84<suppl II):II-20 Downloaded from http://ahajournals.org by on August 17, 2026

Cited by

Sorted by citations

Metadata

Authors
Campos, H., Blijlevens, E., McNamara, J. R., Ordovas, J. M., Posner, B. M., Wilson, P. W., Castelli, W. P., & Schaefer, E. J.
Affiliations
Lipid Metabolism Laboratory, US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Mass. 02111.
Venue
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
Published
1992-12
Volume
12
Issue
12
Pages
1410-1419
ISSN
1049-8834
Cited by
158
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review